iCo Therapeutics iCo Therapeutics Inc.
  • Home
  • Corporate Overview
    • Overview
    • Partnering Strategy
    • Management Team
    • Board of Directors
    • Strategic Advisory Board
    • Professional Advisors
  • Pipeline
    • iCo-007
    • Antisense Technology
    • iCo-008
    • iCo-009
    • Clinical Trials
  • Investor Relations
    • Overview
    • Press Releases
    • Media Coverage
    • Upcoming Events
  • Careers
    • About Vancouver
    • Current Opportunities
  • Contact Us

Investor Relations

Media Coverage

image iCo Therapeutics Announces Licensing Deal

image Antisense Technology

image Pace of iCo Unmatched by Biotech Competitors

image The Wall Street Transcript – March 20, 2006

image Wanted – Buck for Canadian Biotech

image Retina Today – Fall 2006

image iCo in UBC Alumni Magazine 2007.pdf

image

Investor & Media Contact

Frederica Bell, BSc, MBA
Director of Corporate Development
604.602.9414 office
778.385.2549 cell

Contact Us

Items with an asterisk * are required






  • Home
  • Corporate Overview
  • Pipeline
  • Investor Relations
  • Careers
  • Contact Us

Copyright © 2005 iCo Therapeutics Inc. All rights reserved. Terms of Use.